FDG-PET Can Influence Alzheimer's and Dementia Treatments

---

With more than 5 million Americans afflicted with Alzheimer's disease, the cost of care for people with this most common form of dementia continues to increase. How best to maximize the diagnosis and treatment for patients with Alzheimer's, mild cognitive impairment (MCI), and other forms of dementia could be a function of fluorodeoxyglucose (FDG)-PET.

Read more: